Tg Therapeutics, Inc. financial data

Symbol
TGTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2 Gansevoort Street, 9 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
MANHATTAN PHARMACEUTICALS INC (to 4/27/2012), ATLANTIC TECHNOLOGY VENTURES INC (to 3/10/2003), ATLANTIC PHARMACEUTICALS INC (to 2/4/2000)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 424 % +18.7%
Quick Ratio 73.2 % +98.4%
Debt-to-equity 145 % -35.3%
Return On Equity -310 %
Return On Assets -3.4 % +69.1%
Operating Margin -6.92K % -34.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 156M shares +2.81%
Common Stock, Shares, Outstanding 156M shares +2.86%
Entity Public Float 3.4B USD +502%
Common Stock, Value, Issued 156K USD +3.31%
Weighted Average Number of Shares Outstanding, Basic 145M shares +1.56%
Weighted Average Number of Shares Outstanding, Diluted 161M shares +3.11%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.79M USD -58.4%
Revenue from Contract with Customer, Excluding Assessed Tax 265M USD +39.5%
Research and Development Expense 87.9M USD -0.59%
Costs and Expenses 265M USD +40%
Operating Income (Loss) -505K USD +97.3%
Nonoperating Income (Expense) -13.4M USD -92.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -13.9M USD -96.3%
Income Tax Expense (Benefit) 388K USD
Net Income (Loss) Attributable to Parent -14.4M USD +44.6%
Earnings Per Share, Basic -0.08 USD/shares +61.9%
Earnings Per Share, Diluted 0.02 USD/shares -97.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 196M USD +29.8%
Cash, Cash Equivalents, and Short-term Investments 341M USD +48.8%
Accounts Receivable, after Allowance for Credit Loss, Current 116M USD
Inventory, Net 84.7M USD +152%
Other Assets, Current 32.6M USD +170%
Assets, Current 574M USD +79.9%
Property, Plant and Equipment, Net 66K USD -72.2%
Operating Lease, Right-of-Use Asset 7.41M USD -10.4%
Goodwill 799K USD 0%
Other Assets, Noncurrent 2.11M USD
Assets 586M USD +77%
Liabilities, Current 125M USD +117%
Operating Lease, Liability, Noncurrent 8.42M USD -11.6%
Liabilities 394M USD +137%
Retained Earnings (Accumulated Deficit) -1.55B USD -3.51%
Stockholders' Equity Attributable to Parent 192M USD +16.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 40.5M USD -68.7%
Liabilities and Equity 586M USD +77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.21M USD +86.3%
Net Cash Provided by (Used in) Financing Activities 10M USD -60.4%
Net Cash Provided by (Used in) Investing Activities -9.26M USD -50%
Common Stock, Shares Authorized 190M shares +8.57%
Common Stock, Shares, Issued 156M shares +2.92%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.5M USD +57.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 197M USD +29.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.45M USD +40%
Deferred Tax Assets, Valuation Allowance 418M USD +4.48%
Deferred Tax Assets, Gross 418M USD +4.48%
Operating Lease, Liability 9.65M USD -12.3%
Depreciation 68K USD -10.5%
Payments to Acquire Property, Plant, and Equipment 7K USD -89.6%
Lessee, Operating Lease, Liability, to be Paid 13.2M USD -15.3%
Operating Lease, Liability, Current 1.23M USD -16.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.08M USD -0.95%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.1M USD -12.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.58M USD -22.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.91M USD -8.03%
Deferred Tax Assets, Operating Loss Carryforwards 317M USD +4.36%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.83M USD -4.5%
Operating Lease, Payments 600K USD
Additional Paid in Capital 1.75B USD +4.93%
Amortization of Intangible Assets 53K USD 0%
Depreciation, Depletion and Amortization 29K USD -57.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 40M USD +28.3%
Interest Expense 12.1M USD +16.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%